Shareholder Alert: Ademi LLP investigates whether TherapeuticsMD, Inc. has obtained a Fair Price in its transaction with EW Healthcare
prnewswire.com
news
2022-05-31 14:19:00

MILWAUKEE, May 31, 2022 /PRNewswire/ -- Ademi LLP is investigating TherapeuticsMD (NASDAQ: TXMD) for possible breaches of fiduciary duty and other violations of law in its transaction with EW Healthcare. 
Click here to learn how to join the action: https://www.ademilaw.com/case/therapeuticsmd-inc or call Guri Ademi toll-free at 866-264-3995.  There is no cost or obligation to you.
Ademi LLP alleges TherapeuticsMD's financial outlook and prospects are excellent and yet TherapeuticsMD holders will receive only $10.
